Literature DB >> 1423912

Acute hemodynamic effects of hypertonic (7.5%) saline infusion in patients with cardiogenic shock due to right ventricular infarction.

J A Ramires1, C V Serrano Júnior, L A César, I T Velasco, M Rocha e Silva Júnior, F Pileggi.   

Abstract

The hemodynamic effects, after infusion of 4 ml/kg of hypertonic (7.5%) saline solution (HS), were evaluated in six patients (mean age = 56.6 years) with cardiogenic shock (CS) due to right ventricular infarction (RVI). Basal condition data (mean +/- SEM) were as follows: cardiac index (CI) = 1.9 +/- 0.1 1/min/m2, arterial pressure (AP) = 66.5 +/- 0.9 mmHg, and systemic vascular resistance (SVR) = 31.3 +/- 1.0 mmHg/1/min/m2. Five- and 240-minute post-HS infusion data (respectively) revealed: CI = 3.3 +/- 0.1* and 2.9 +/- 0.1* 1/min/m2, AP = 87.7 +/- 1.6* and 80.7 +/- 2.2* mmHg, and SVR = 22.5 +/- 0.6* and 24.5 +/- 1.1* mmHg/1/min/m2 (*P less than 0.05 compared to baseline values). These data suggest that small-volume infusion of HS induced an important acute and sustained hemodynamic improvement in these patients with CS due to RVI.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1423912

Source DB:  PubMed          Journal:  Circ Shock        ISSN: 0092-6213


  5 in total

Review 1.  [Small-volume resuscitation for hypovolemic shock. Concept, experimental and clinical results].

Authors:  U Kreimeier; F Christ; L Frey; O Habler; M Thiel; M Welte; B Zwissler; K Peter
Journal:  Anaesthesist       Date:  1997-04       Impact factor: 1.041

Review 2.  Hypertonic saline: a clinical review.

Authors:  R Tyagi; K Donaldson; C M Loftus; J Jallo
Journal:  Neurosurg Rev       Date:  2007-06-16       Impact factor: 3.042

3.  Acute treatment of uncompensated heart failure with 10% hypertonic saline and its subsequent effect on respiratory patterns.

Authors:  Fernando Godinho Zampieri; Pedro Caruso
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

4.  Hypertonic saline protects brain endothelial cells against hypoxia correlated to the levels of epidermal growth factor receptor and interleukin-1β.

Authors:  Sheng-Long Chen; Yi-Yu Deng; Qiao-Sheng Wang; Yong-Li Han; Wen-Qiang Jiang; Ming Fang; Bei Hu; Zhi-Xin Wu; Lin-Qiang Huang; Hong-Ke Zeng
Journal:  Medicine (Baltimore)       Date:  2017-01       Impact factor: 1.889

Review 5.  Current strategies for preventing renal dysfunction in patients with heart failure: a heart failure stage approach.

Authors:  Victor Sarli Issa; Lúcia Andrade; Edimar Alcides Bocchi
Journal:  Clinics (Sao Paulo)       Date:  2013       Impact factor: 2.365

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.